RBC Life Sciences, Inc.
RBC Life Sciences, Inc., a prominent player in the biotechnology and life sciences sector, is headquartered in the United States. Founded in 1997, the company has established itself as a leader in the development and distribution of innovative health products, particularly in the fields of nutritional supplements and diagnostic testing. With a focus on enhancing health and wellness, RBC Life Sciences offers a unique range of core products, including proprietary formulations that cater to various health needs. The company’s commitment to quality and scientific research has positioned it favourably in the competitive life sciences market. Notable achievements include significant advancements in product efficacy and a growing presence in key operational regions across North America.
DitchCarbon Score
How does RBC Life Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RBC Life Sciences, Inc.'s score of 33 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RBC Life Sciences, Inc.'s reported carbon emissions
In 2022, RBC Life Sciences, Inc. reported total carbon emissions of approximately 65,577,000 kg CO2e from Scope 2, 22,840,000 kg CO2e from Scope 1, and 11,920,000 kg CO2e from Scope 3. This data indicates a commitment to transparency in their emissions reporting across all three scopes. RBC has set ambitious near-term reduction targets, aiming for a 36% reduction in absolute emissions for both Scope 1 and Scope 2 by 2030, compared to 2020 levels. This aligns with global efforts to mitigate climate change and reflects the company's proactive stance in addressing its carbon footprint. In the long term, RBC is also committed to achieving net-zero emissions for Scope 1 and Scope 2 by 2060, in line with emerging global standards and targets set by various countries. This commitment underscores RBC's dedication to sustainability and its role in the broader context of climate action. Overall, RBC Life Sciences, Inc. is actively working towards significant emissions reductions while maintaining transparency in its climate commitments, positioning itself as a responsible player in the life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 24,821,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 102,009,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 31,741,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RBC Life Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
